Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 23, 2020 17:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Grants Stock Options

SAINT-LAURENT, Quebec, Nov. 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTCQB:IGXT) announced today that the Company’s board of directors...
November 12, 2020 16:05 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reports Third Quarter 2020 Financial Results

SAINT LAURENT, Quebec, Nov. 12, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the third quarter...
November 11, 2020 08:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Issuance of U.S. Patent for Novel Technology Applicable to Cannabis-Containing Oral Films

SAINT LAURENT, Quebec, Nov. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the United States Patent...
November 09, 2020 08:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Publication of a Study Evaluating Montelukast’s Effect on Neurological Aging

- Data Suggest Montelukast May Inhibit Mental Decline, Higher Doses Optimal for Clinical Trials Assessing Impact on Neurological Disease - SAINT LAURENT, Quebec, Nov. 09, 2020 (GLOBE NEWSWIRE) --...
November 05, 2020 16:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Report Third Quarter 2020 Financial Results on November 12, 2020 – Conference Call to Follow

SAINT LAURENT, Quebec, Nov. 05, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its third quarter 2020 financial results after...
October 29, 2020 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Signs Letter of Intent with Heritage Cannabis for Long-Term Cannabis Filmstrip Supply Agreement

SAINT LAURENT, Quebec, Oct. 29, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has executed a binding letter of intent...
October 23, 2020 19:15 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Second Tranche Closing of Private Placement

SAINT LAURENT, Quebec, Oct. 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) is pleased to announce that it has closed a private...
October 21, 2020 07:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for Adversa® Mucoadhesive Delivery Technology for Dronabinol

SAINT LAURENT, Quebec, Oct. 21, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has entered into an amended and restated...
October 15, 2020 19:38 ET | Source: IntelGenx Technologies Corp.

IntelGenx Closes U.S.$1.2 Million Private Placement Financing

SAINT LAURENT, Quebec, Oct. 15, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces the closing of an offering by way of private...
August 27, 2020 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx and Exeltis Healthcare S.L. Expand RIZAPORT® Commercialization Agreement to Include the European Union

- Agreement Adds 26 Countries to Commercial Territory, with Initial Sales Expected in Early 2021- SAINT LAURENT, Quebec, Aug. 27, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT)...